Resiquimod (GMP)

Overview

Resiquimod (R848) (GMP) is Resiquimod ( HY-13740 ) produced by using GMP guidelines. GMP small molecules work appropriately as an auxiliary reagent for cell therapy manufacture. Resiquimod is a Toll-like receptor 7 and 8 ( TLR7/TLR8 ) agonist. Resiquimod (GMP) can induce human mMDSC to mature into inflammatory macrophages.

Application

Products | Products > GMP Small Molecules | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Signaling Pathways > Toll-like Receptor (TLR)

Product Information

• Catalog No.: HY-13740G
• CAS No.: 144875-48-9
• Molecular Formula: C17H22N4O2
• Molecular Weight: 314.38
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source